Skip to content

Impact of remote digital pulmonary rehabilitation on cardiopulmonary function and other prognostic factors in post-surgical elderly patients with lung cancer : a multicenter randomized controlled trial

Impact of remote digital pulmonary rehabilitation on cardiopulmonary function and other prognostic factors in post-surgical elderly patients with lung cancer : a multicenter randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117207
Enrollment
Unknown
Registered
2026-01-21
Start date
2026-01-25
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Experimental group:The training terminal delivers daily rehabilitation training content to the WeChat mini program on the patients mobile device, enabling patients to conduct home-based rehabilitation
Control group:Conduct routine postoperative discharge rehabilitation education for lung cancer patients and distribute postoperative rehabilitation education manuals for lung cancer. Therapists will g

Sponsors

The First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: All subjects were hospitalized thoracic surgery patients: 1. Age: 60~80 years old; 2. Expected to undergo surgery for lung cancer; 3. Postoperative pathology confirmed non-small cell carcinoma (squamous cell carcinoma, adenocarcinoma); 4. The clinical stage was stage I-IIIA; 5. Able to use tele-rehabilitation diagnosis and treatment system (including with the support of family members); 6. Able to cooperate with researchers to follow up on time; 7. The expected survival time is greater than 1 month; 8. Voluntarily participate in the experiment and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. with severe cognitive impairment, hearing or visual impairment, with concurrent tumors in other parts of the body or severe systemic diseases; 2. with limited ability to participate in the intervention due to heart failure (New York Heart Association functional class III and IV), cerebrovascular diseases (such as cerebral hemorrhage, cerebral infarction, transient ischemic attack, stroke or cerebrovascular accident), walking difficulties (such as arthritis, osteoporosis, joint pain or rheumatoid arthritis), or kidney diseases (such as chronic renal failure); 3. difficult to walk even with the aid of a walking stick 4. participation in other clinical studies.

Design outcomes

Primary

MeasureTime frame
peak VO2;

Secondary

MeasureTime frame
Pulmonary function;Muscle strength;Cardiorespiratory endurance;Quality of life;Pulmonary complications after lung cancer surgery;Frailty status;

Countries

China

Contacts

Public ContactMao Mao

The First Affiliated Hospital of Nanjing Medical University

super_fox12@163.com+86 137 7070 5500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026